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ABSTRACT

Over 21 million American wanen suffer fra:n the chronic, cyclic,
psychoneuroendocrinological dysfunction knawn as premenstrual syndrare
(PMS)

(Greenfield

&

Wolf, 1983) • . At least five million of these

WOffi2I1

suffer fran symptoms so debilitating that their :personal and/or
professional lives are disrupted (Labrum, 1983).

Women who suffer fra:n

PMS often seek counseling because of the syndrome's behavioral,
affective, and errotional corrq;x:ments.

Mental heal th professionals IIU.lst

be prepared to aid both the client and her gynecologist in the

diagnosis and treatment of PMS.

This research re:port includes (1) a

synopsis of the medical literature including some of the theories of
etiology and treatment procedures, (2) a review of the psychiatric
ramifications and psychological treatments of PMS, and (3) a PMS Packet
designed to aid mental health professionals and their clients in the
evaluation of PMS.
It is unknown whether PMS is a disease or a physiologically
abnonral rrenstrual cycle which appears to be quite comrron (Sanders,
Wa01er, Backstrom, & Bancroft, 1983; Shangold, 1983).

Nonetheless,

wcxnen with prenE.nstrual syndrorre need and deserve our attention and

best efforts at finding the cause(s) and the appropriate treatm:mts.
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INTRODUCTION

Fifty-five years have passed since Dr. Robert T. Frank first
described what is now comrronly referred to as prerrenstrual syndrOITE
(PMS).

When Frank presented his thesis, "'Ihe Honronal Causes of

Prerrenstrual Tension,'' at a rreeting of the Section of Neurology and
Psychiatry at the New York Academy of Medicine, he believed that PMS
was the result of too high levels of estrogen (Backstrom, Bancroft,
Bixo, Hanmarback, & Sanders, 1982).

Despite the lack of sophisticated

diagnostic techniques, recent evidence supports Frank's contention that
PMS is a medical condition with an endocrinological basis (Dalton, 1984;
Harrison, Endicott, Rabkin, & Nee, 1984).

Tcxlay there are blood serum

tests and radioimrunoassay, the technique which allows measurerrent of
very sma.11 honnonal levels in the blood • . Unfortunately, even with
these and other assessment tools, a reliable laboratory test for PMS
does not yet exist (Shangold & Shangold, 1984).
Several theories of etiology continue to be espoused and tested
by medical professionals.

They include, but are not limited to, an

imbalance or dysfunction of gonadal steroids, prolactin, and prostaglandins (Chakmakjian, 1983; Janowsky, 1985; Steiner & Carroll, 1977).
Historically, psychiatrists have attempted to explain PMS etiology in
psychodynamic terms (Bernsted, Luggin,
Wilson, 1984).

&

Petersson, 1984; Budoff., 1983;

.

Now there is overwhelming evidence that premenstrual

syndrarre is, in fact, an endocrine disorder and not a psychiatric
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disease (Abplanalp, 1983a; Dalton, 1984; Lauersen & Stukane, 1983).

It

seems clear, however, that regardless of etiolCXJY, emotional and
situational factors play an :important role in the subjective experience
of PMS (Clare, 1983; Dennerstein, Spencer-Gardner, & Burrows, 1984).
'Ihus, mental health professionals can use their expertise to develop
individual, rmrital, and family therapy nod.els, to employ coping
strategies, and to research how stress and :personality variables effect
premenstrual syndrome.

Both the rredical and mental health ccmmmities

have begun a much needed collaboration in an attempt to effectively
treat PMS pcttients and their families.
-43ecause the ferrale cycle is horrronally based, a woman experiences
physical and psychological changes prior to the onset of rrenses.
Sorretiroes these behavioral, sorratic, and affective changes ma.y be
uncomfortable and unpleasant, but for the most pctrt, they are not so
- severe as to limit a woman's ability to adequately deal with them.

For

others, at least 40% of the female population between the ages of 14
and 50, such premenstrual changes are serious enough to warrant
rredical and/or psychological intervention (Blumenthal, 1983; Hamilton,
Parry, Alagna, Blumenthal, & Herz, 1984; Lauersen & Stukane, 1983;
Laughlin & Johnson, 1984; Shangold & Shangold, 1984).
YX.>men

to whcm researchers refer as having PMS.

These are the

Of this group, a

sma.11 :percentage, approximately 10%, suffers from a severe for:m of PMS
(Backstrcm et al. , 198 2; Lauersen

&

Stukane, 198 3) •

For these warren,

nedical and psychological treat:rrent are usually required because their
symptoms are disabling enough so as to disrupt both their professional
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and personal lives.

Their lives are so ccmpletely controlled by their

condition that intervention is critical.

It is for all of these warren

that both the medical and mental health ccrrmunities are actively
seeking answers.

However, PMS is not just a wanan' s issue.

A wcm:m is

not an isolated being; her family, career, and friends are all affected
by her physical and m.::ntal health.

It is to the benefit of everyone

that the causes and treatments of premenstrual syndrome are better
understocx:l.
Finally, please note that this research report will only refer to
this disorder as preirenstrual syndrome or PMS, unless a researcher is
being quoted.

In the latter case, the researcher's tenn for PMS will

be used within his/her intended context.

'Ihe rrost controversial label

found in the literature is prerrenstrual tension (PMT).

Premenstrual

m::x:x1 changes (PMC) has also been mentioned in the literature (Hamilton

et al. , 1984) , as has premenstrual tension syndromes (PMTS) (Abraham,
1983b) and premenstrual tension syndrome (PTS) (Steiner & Carroll,
1977).
The acronym, PMr, appears to address only one aspect of the
syndrome, that of nervous tension.

Even though it rray well be the rrost

comronly re:ported symptom (Rubinow, Roy-Byrne, Hoban, Gold, & Post,
1984), this pa.rticular symptorn does not appear to be present in all
PMS pa.tients (Norris, 1983).

When it does occur, it is typically

accanpanied by other syrtq?torns simultaneously (Rubinow, Roy-Byrne,
Hoban, Gold,

&

Post, 1984).

While it rray be true that psychologists

recognize that clients with enotional symptarrology are as deserving
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of treat:mcmt as any pc:t.tient with physiological symptorrology, it is
llnportant to realize that historically warren have been discredited
and derreaned by gender based classifications of rrental disorders and
research methods (Koeske, 1983).

Within this context, it becorres

clearer why a label such as PM!' has been rejected in :rruch of the
current scientific and popular press literature (Abplanalp, 1983b;
Greenfield & Wolf, 1983; La.uersen & Stukane, 1983; Ia.ughlin & Johnson,
1984; London, Sundaram, Murphy, & Goldstein, 1983; Long, 1985;
Shangold, 1983; Wilhelm-Hass, 1984).

CHARACI'ERISTICS OF PREMENSTRUAL SYNDroME
When diagnosing PMS, the doctor or clinician should first look at
the timing of the symptoms.
client experiences

a

It is critical to the diagnosis that the

symptom-free period follo.ving the onset of rrenses.

If she does not experience such a relief period, then one of two
possibilities exists; either she does not have PMS at all, or she has
PMS and another condition 'Which is confounding a clear diagnosis .
(White, 1985).
According to current opinion, a woman who has PMS experiences her
symptoms 2 to 14 days prior to her menstruation and then experiences a
symptom-free period (Lauersen & Stukane, 1983).

An operational

definition requires that (a) the types of symptoms observed be
specified, (b) the intensity of the symptoms during both the
premenstrual and intermenstrual phases be described, (c) the timing
of the symptoms be detennined as explained above, and (d) consistency
in timing in relation to the onset of menstruation be derronstrated in
at least two, and preferably three, menstrual cycles (Rubinow,
Roy-Byrne, Hoban, Gold, & Post, 1984).

The clinician needs to take

into consideration, however, that one woman's syrnptans may, in fact,
vary from nonth to m::>nth in type, intensity, and/or duration.

In

general, this operational definition m::rlel is extrerrely useful as a
first step to treat:nEnt, -that is, as a diagnostic tool.
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Although PMS appears to involve several overlapping syndrares
(Abraham, 1983a; Harrison et al., 1984; Rubinow, Roy-Byrne, Hoban, Gold,
& Post, 1984), it is helpful to first examine the three categories of

symptoms which are most often experienced and observed.

As

stated

above, a wonan can have symptoms from one or rnore categories at the
sarre tine.

Each PMS client is unique in her Symptorrology.

attempting to understand the etiology of this

syndr~,

lose sight of the individuality of each case.

Thus, in

one should not

A list of sane of the

physical, affective, and behavioral symptoms is presented here (Abraham,
1982; Budoff, 1983; Labrum, 1983):
Physical Symptoms
fatigue

dizziness

lethargy

pruritis

increased appetite

headache

thirst

frequent urination

acne, cold sores

irritated eyes

diarrhea

sensation of weight gain

constipation

bloated feeling in abdorren

pain in the breast

pain in joints

breast tenderness

swelling in joints

increased libido

subcutaneous herrorrhaging .

palpitations

a sense of internal shaking

paresthesia

breathlessness

~ craving

for sweets (especially chocolate), salty foods,

alcohol, and/or refined carbohydrates
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Affective Symptoms
depression

panic attacks

exciterrent

anxiety

tension

hostility

agitation

frequent rrood swings

dysphoria

feelings of helplessness

egodystonia

feelings of aggression

irritability

paranoid ideation

anger

suicidal ideation

feelings or fear of losing control
Behavioral/Cognitive 8ymtoms
insannia

burst of energy

apathy

heightened creativity

forgetfulness

crying spells

food binging

difficulty with :rcotor coordination

alcohol binging

difficulty thinking rationally

isolation/withdrawal

difficulty with verbalization

hypersensitivity to sound, sight, and touch
other Characteristics of PMS
an adverse reaction to oral contraceptives
a family history of wanen with similar syrnptorrology
a history of postpartum depression
develo:i;m::mt of toxemia during pregnancy
relief of symptoms during last six :rronths of pregnancy
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symptoms worsening with age
feelings that nenopause must be _occurring
alcohol intolerance in premenstrual phase
increase in f ibrocystic breast disease (FD) synptoms during the
premenstrual phase
'Ihese are just sorre of the symptoms nentioned in 1:.L'1e literature.
As many as 150 symptoms have been observed in patients with PMS

(Abraham, 1982; Hamilton, 1984; Rubinow & Roy-Byrne, 1984).

Sane

patients experience a worsening of their allergies, glaucana, and
asthrra (Lauersen

&

Stllkane, 1983).

For same women who suffer from

epilepsy, seizures occur nore frequently during the premenstruurn
(Budoff, 1983; Steiner & Carroll, 1977; 'White, 1985).
The biological causes of these symptans will be discussed later.
'Ihe tines when these symptoms can occur in a wanan's life will be
examined first.
Premenstrual syndrom:; usually begins after any najor honnonal
change or stress.

'Ihe rrost cormon exarcples are following pregnancy,

after using an oral contraceptive, and in som:; rare cases, following
puberty.

PMS is rare in adolescence, and nost carm::>n in the third

decade of life (Hamilton, 1984; Wilson, 1984).

Any significant

interruption of the horrronal cycle can trigger preirenstrual syndrome.
Sorretimes a tubal ligation or a hysterectaey in which the ovaries are
left can bring on the symptctns described above (Backstrom et al., 1982).
One popular classification system for PMS was designed by Guy E.
Abraham and published in 1981.

Abraham used the term "pre:rrens-t rual

9

tension" to classify four subgroups of this condition; PMT-A, PMr-H,
PM:r-C, and PMr-D (Abraham, 1982).

Each initial following the acronym,

PMT, is representative of the cluster of symptans in that subgroup.
PMT-A stands for a cluster featuring anxiety as its nost corrrocmly
reported symptom.

Other SJ:7ItlPtams of PMT-A sufferers are hostility,

tension, and SC'llretimes a mild to rrnderate depression.

This is the nost

comm::m subg.r oup of PMS and occurs in 80% of PMS sufferers, according
to Abraham.

These syrnptans tend to increase in severity as rrenses

approaches (Abraham, 1982).
PMr-H stands for a group of symptans featuring the feeling of
heaviness or swelling as its rrost comnon problem.

Although warcen do

not actually gain rrore than three pounds usually, they do report that
they experience the sensation of weight gain, tenderness in the breasts,
rnastalgia, breast congestion, and abdominal bloating.

PMr-H occurs in

60% to 66% of all PMS sufferers (Abraham, . 1982).
Approximcttely 40% of PMS patients report having PMT-C symptoms.
These warren have cravings for sweets (especially chocolate), salty
foods, alcohol, and/or refined carbohydrates (Abraham, 1982).

After

binging, they usually experience a hypoglycemic type of reaction
including syncope, dizziness, fat{gue, palpitations, and headaches.
Research has shown that the preIIEnstrual craving of refined sugar
and feelings of tension related to stress positively correlate
(Lauersen & Stukane, 1983).

The rranagem:mt of stress and proper

nutrition play a ma.jor role in the treatment of PMr-C (Abraham, 1982).
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Finally, it is estimated that between 3% and 5% suffer from
PMI'-D.

For them, depression is the ma.jor symptom and it is often

incapctcitating.

These women require rredical and psychological

intervention on their behalf.

Other symptoms of PMr-D are lethargy,

suicidal ideation, pctranoid ideation, and difficulty with verbalization,
rrotor coordination, and rational thinking. · If PMr-D ·i s severe, the
pcttient may be too depressed to seek help.

If Pr-tr-D coexists with PMr-A,

as is the case with 20% of the PMS popluation, according to Abraham,
then the situation is usually not as life-threatening (Abraham, 1982) .
However, in cases where severe depression and agitation are concurrent
symptans, a psychological evaluation is necessary to properly assess
whether or not she is a danger to herself or others.
Abraham's invaluable classification system marked a turning point
in how pcttients with PMS were viewed.

Although pcttients nay have

syrrptans from one or rrore categories, this system provided a place to

start in the difficult task of assessrrent.

HORMJNAL CHANGES IN MENSES AND MENOPAUSE

Before reviewing several of the proposed hYf>Otheses of the etiology
of PMS, an understanding of the neuroendocrinology of the nonna.l
menstrual cycle nn.ist be reached.

Menstruation and .IIEnopause are nonna.l

develo:prrental stages in a woman's life, and both have different .but
profound effects on her.
Menstruation
'Ihe purpose of menses is reproduction.
ages of 10 and 16, puberty occurs.

At some time between the

Development of ovaries and

secondary sex characteristics occur because the anterior pituitary
gland begins to increase the production of follicle-stimulating
horrcones (FSH) called gonadotropins.

'Ihis pituitary gland production

is in resp::>nse to a hypothalamic releasing factor, or gonadoptropin
releasing ho:rrrone (GnRH).

After puberty and until rrenopause, FSH is

released once a rconth except during the time a von:m is pregnant.

For

rrost women, the menstrual cycle lasts from 20 to 35 days.
'Ihe menstrual cycle is divided into two phases, the follicular
phase or postmenstruum, and the luteal phase or prerrenstruum (see
Appendix I) .

Each of these two phases can be further divided into

three parts:

early follicular, mid-follicular, late follicular; and

early luteal, rnid-luteal, and late luteal (Sanders, Warner, Backstrom,
& Bancroft, 1983).
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Follicular Phase
Although the number of days varies, the follicular phase is
usually regarded as the first 13 days of the rrenstrual cycle, beginning
on the first day of menstrual flow.

This two-week :period of time is

important for the PMS client, because it is during the follicular phase
that she is free of symptoms.
Menstrual flow occurs because the egg is not fertilized or because
the zygote fails to embed itself :in the endornetrium.
ends, a new cycle beg:ins.
pituitary gland.

As

rrenstruation

'Ihe hypothalanru.s sends the GnRH to the

'Ihis gland then releases the FSH to the ovaries so

that estrogen can be produced.

So nuch FSH is produced that the

growth of follicles in the ovaries is stimulated each :rronth.

But only

one follicle, the graafian follicle, produces the ovum that will travel
through the fallopian tube to the uterus.

Dur:ing the follicular phase,

estrogen is being produced, st:imulat:ing the growth of the uterine
lining so that it fonns a suitable environrrent :in which the zygote can
implant itself.

Estrogen is produced by the graafian follicle

conta:ined in the ovary which will ovulate that particular rrenstrual
cycle.

By the last day of the late follicular phase, estrogen

production peaks.

The pituitary gland res:ponds to this estrogen peak

by releasing luteinizing honrone (LH) and stopping FSH (I..ahlreyer, 1984;
Sanders et al., 1983; Steiner & Carroll, 1977; White, 1985).
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Luteal Phase
The lli surge nakes the graafian follicle rupture, thereby releasing
a mab.lre egg.

A mature egg is prcxluced in approximately one week and

when it is released, ovulation has occurred, thereby 11l3.rking the
beginning of the second stage, the luteal phase.

This- phase is usually

regarded as being the 14 days prior to menstruation.

This is because

it takes 14 days for the ovum to travel from the ovary to the interior
of the uterus.

During the luteal phase, the emptied graafian follicle

becares the corpus luteum, a terrporary body which secretes the horrrone,
progesterone.

Progesterone is secreted in increasing arrounts for

approx.ima.tely seven days following ovulation.

A woman's body

temperature rises slightly and stays elevated for the duration of the
mid-luteal phase if progesterone is prcxluced in sufficient quantities.
As

rrEntioned above, estrogen peaks in the late follicular phase.

After ovulation, the concentration of estrogen falls, then rises until
it peaks again in the mid-luteal phase.

'!his post-ovulatory increase

in both estrogen and progesterone is necessary to further develop the
endometrium for its possible reception of a zygote.
If the ovum is not fertilized, then the corpus luteum secretes
less and less arrounts of prOCJesterone until it finally stops altOCJether.
The estrogen and progesterone levels fall around day 23 or 24 of the
cycle.

Menses will then follow within a few days.

If a wanan conceives, her prOCJesterone will not drop in the late
luteal phase as it nonrally does before rrenstruation.

The corpus

luteurn will continue to grow and secrete progesterone and estrogen
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for the first tr:lrrester of pregnancy.

The placenta will gradually

. assurre this important role of horm::::>nal production (Lahrreyer, 1984;
Sanders et al., 1983; Steiner & Carroll, 1977; White, 1985) .
. Menopause
Every

WOTIE.n

eventually experiences rnenopause, the cessation of

rrenses, either surgically or naturally.

'!he perirrenopausal period is

the 10- to 15-year period prior to natural menopause when a woman may
notice sorratic changes, such as irregular rnenstrual cycles.

As

the

body decreases its production of estrogen, a corrnon sorratic change
experience, known as the hot flash, may occur.

'Ihis symptom can

occur 4 to 8 years prior to the last rrenstrual period (LMP), and 89%
of

VJ0rneI1

who experience natural rnenopause will experience this

uncanfortable symptom.

Menopause has not officially occurred until 12

consecutive, rrenses-free nonths have passed since the I.MP.

If a woman

has her uterus and ovaries rerroved, she is i.mrediately rrenopausal.

Her

gynecologist will :rrore than likely prescribe estrogen replacerrent
therapy

(ERr)

if she is experiencing rrenopause sooner th.an she would

have naturally, or if her symptcms interfere with her personal and
professional life.

Women 'Who experience rnenopause used to be seen in

an illness :rrodel, as patients 'Who were estrogen deficient.

But now

this is viewed as a normal stage in a wanan's life, and postponing
the symptcms that no:r:ma.lly accompany rrenopause by the use of ERr is
not necessarily the treatment of choice for all women (Vada & Eliasson,
1983).
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Sane researchers have suggested that perim=nopausal symptans are,

in fact, a continuation of prenenstrual syndrorre symptans.

A

gynecologist may treat this wanan as a_ PMS patient, rather than a
perirrenopausal patient, to see if her synptarrology can be relieved by
methods rcore natural than ERr (Hargrove & Abraham, 1983).

PROPOSED BIOLOGICAL ETIOLOGIES AND TPEATMilTI'

Many theories have J?een proposed to explain the etiology of PMS.
As stated earlier, researchers continue to investigate nUIIErous

hypotheses including, but not limited to, how estrogen, progesterone,
endogenous opiate peptides, nutrition, prolactin, and prostaglandins
may each play a role in why PMS occurs.

Several researchers have

provided thorough overviews of PMS literature during the past decade
(Abplanalp, 1983a; Abraham, 1983b; Dennerstein et al., 1984; Rubinow &
Roy-Byrne, 1984; Steiner & Carroll, 1977).

Although PMS can occur in

the presence of an apparently normal luteal phase (Backstrom et al.,
1983), biological theories of the causes of PMS center around this
stage of the menstrual cycle since the follicular stage is symptom-free
for PMS patients.
All authorities agree that prior to any treatment, a woman should
have a complete physical examination by a qualified gynecologist.
is an essential step in the diagnosis of PMS.

This

'Ihe gynecologist should

perform a pelvic examination to look for any evidence of ovarian cysts,
uterine fibroids, pelvic inflamna.tory disease, and endaretriosis.

"Any

one of these can cause symptoms similar to those associated with PMS
(I.a.ughlin

&

Johnson, 1984).

He/she should also perfonn a breast

examination to check for any suspicious mass, fibrocystic breast
disease, tenderness, and galactorrhea, a continued and excessive flow
of breast milk.
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Although their value is controversial, serum laroratory tests can
be useful.

'!hey include, but are not limited to, FSH, IB, estradiol,

prolactin, and progesterone levels.

If blood serum levels are taken,

they should be obtained in the mid-luteal or late luteal phase.

'Ihe

dcx::tor nay also order a complete blood count (CBC), a Papincalaou
(pa.p smear), testosterone level, dehydroepiandrosterone sulfate levels,

and dexarrethasone suppression test (Lauglin

&

Johnson, 1984).

~ause

of the importance of ruling out other endcx::rinological disorders, a
thyroid check is critical (Leibnann-Smith, 1985; Wilhelm-Hass, 1984).
Some women with PMS symptorrology ffi3.y, in fact, be suffering from a
thyroid problem (Labrum, 1983).

It has been estlirated that as :rrany as

67% of all PMS cases ffi3.Y implicate the thyroid (Leibrnann-Srnith, 1985).
Estrogen and Progesterone
Perhaps the rrost familiar narre asscx::iated with PMS is that of
Dr. Katharina Dalton.

She continues tO be the foremost proponent of

natural progesterone therapy, and has administered it in her native
England for m3.IlY years.

Dalton reports that she has successfully

treated PMS patients who suffer from irritability, anger, and hostility.
She believes that the warren who ext:erience these symptans have
insufficient arrounts of progesterone and excessive arrounts of estrogen
during the luteal phase of the menstrual cycle.

It has also been

theorized that the symptom of hostility ffi3.Y be the result of unopposed
testosterone during the late luteal phase, when progesterone and
estrogen production abruptly diminishes (Kaplan, 1984).

Although

Dalton's successes have not been duplicated in double-blind studies,
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it is well-kna..m that literally thousands of wom::m have been reportedly
helped by her treatrrent (Budoff, 1983; Chakmakjian, 1983; Iauersen &
Sblkane, 1983; Wilson, 1984).

Natural progesterone therapy has not

helped wanen whose prinary symptom is depression.

This is probably

because these patients do not have significantly deficient plasma
progesterone levels during the late luteal phase (Steiner & Carroll,
1977).
Because it has to bypass the digestive tract, progesterone Im.1st be
administered in a starter dose of 400 mg. by vaginal or rectal
suppository or 50 mg. by intramuscular injection, on a daily basis
during the entire luteal phase (Budoff, 1983).

The ¢losage is increased

after the first cycle until a therapeutic level is found.

'Ihe

therapeutic dose is continued for three rronths before any attempt at a
reduction is made.

SorrE patients may need this treat:rrent for only a

few rronths, while others may require its continuance until rrenopause.
Although there is alrrost no chance of overdose with progesterone
(Norris, 1983), it can produce sorre mild side effects such as a diuretic
effect, yeast infection, vaginal swelling, mild depression, headache,
exhaustion, uterine bleeding, and lightheadedness (Hamilton et al.,
1984; Wilson, 1984).

Progesterone is expensive and not routinely

available in the United States, and has yet to be approved for the
treatment of PMS by the Food and Drug Administration (Norris, 1983).
Because it cannot be patented (La.uersen & Stukane, 1983), it is
unprofitable for the phanna.ceutical industry to market progesterone
suppositories (White, 1985).

Progesterone is available in powder fonn

19
and a pharmacist can legally use it with other chemicals to In3.ke
suppositories, although this is usually expensive.

Nevertheless,

it is an option for warren, and sare have taken advantage of it to
relieve their PMS symptoms.
Because estrogen binds salt and salt binds water, it has been
theorized that we.men who suffer cranial dilation resulting in
premenstrual migraine headaches may have an excessive anount of
estrogen.

Estrogen appears to induce salt and fluid retention by

increasing mineralocortocoid levels (Shangold, 1983).

Although

controversial because of their adverse side effects, diuretics have
relieved symptoms of fluid retention.

'Ihe administration of 25 mg. of

spironolactone, four times a day during the luteal phase, is an
effective treab:rent 'Which, in sare studies, has proved to be superior
to placebo (Shangold & Shangold, 1984).
Progesterone is a depressant of the central nervous system and
the balance of estrogen and progesterone has a profound effect on rrood
(.Abraham, 1982).

If progesterone is too high in relation to estrogen

during the

phase, the patient may exhibit clinical depression.

lu~l

'Iherapy ITU.1st be individualized according to the results of a serum
evaluation as detailed above, but in general, srcall doses of estrogen
help to relieve this patient's symptoms (Chakrcakjian, 1983).

It is

critical to assess whether or not depression is occurring alone or in
conjunction with prertEnstrual anxiety and tension if the client is to
receive adequate treatment.

As stated earlier, the percentage of the

ferrale population which is effected by severe prerrenstrual symptans,
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such as depression, is perhaps 3% to 5%, or five to six million warren
(Labrum, 1983) •

It is this specific group of vonen for

whom

rredical

intervention is probably most critical, due to the severity of their
symptorrology and i;x:>ssible hannful consequences to themselves and/or
others (Norris, 1983).
If a woman's presenting problems include fatigue, constipation,
abdominal pain, and a history of vaginal infections, the doctor

rr0.y

want to refer her to an allergist for a candida albicans evaluation.
'Ihe growth of candida is prorroted by the increased prcx:luction of
progesterone in the luteal phase, and such a disorder is often
exacerbated by oral contraception which contains synthetic progesterone
(Crook, 1983).

Endoc;enous 0piate Peptides
Endogenous opiate peptides, rrore comrronly known as endorphins, are
rrost active during the mid-luteal phase.

fue stimulus for that activity

is theorized to be the luteal phase increase in estrogen and/or
progesterone prcrluction.

It is believed that endorphins control levels

of prolactin, vasopressin, and prostaglandins.

'Ihe increased endorphin

activity of the mid-luteal phase nay cause m:xx1 change, thirst, increase
in appetite, nastydonia, and edema.

Other PMS symptans of anxiety,

tension, and hostility nay be the result of the abrupt decrease in
endorphin prcrluction during the late luteal phase (Laughlin & Johnson,
1984).

'Ihis occurs at the sane tlire the production of estrogen and

progesterone has dropped dram:ttically. .
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Pyridoxine Deficiency and Nutrition
Excess of estrogen rray also be caused. by the liver's inability to
deactivate the estrogen because of a B vitamin or pyridoxine deficiency
(Abraham, 1982; Chakrnakjian, 1983; Laughlin

&

Johnson, 1984).

Abraham

believes that alrrost all .PMS patients experience significant symptom
improverrent when vitamin B6 and nagnesium supplerrents are added to the
diet (Chakrnakjian, 1983).

In

general, PMS patients are known to consum2

rrore refined sugar, refined carbohydrates, dairy prcx:lucts, and have
lowered red-cell nagnesium levels, while warren who do not have PMS
conS\.llre rcore B vitamins, iron, zinc, and nanganese (Goei

&

Abraham,

1983).
Pyridoxine acts as a coenzyrre in the biosynthesis of dopamine and
serotonin from tryptophan.

'Ihis theory of etiology, involving hepatic

enzymes, metabolism, and pyridoxine, rray play a part in preirenstrual
depression and irritability.

PMS patients with edema., headaches, focrl

cravings, depression, m:xXl swings, and irritability are usually given
50-300 mg. of vitamin B6 per day in three doses during the luteal phase
(Ahlgrinm, 1985).

However, this treat:m::mt is not recomrended without a

daily dosage of 100 mg. of B complex vitamins all cycle long.
Pyridoxine is inexpensive and readily available over the counter.
Adverse side effects are possible with ·e.xcessive ingestion (Ahlgrirrm,
1985; Shangold, 1983), but such an overdose is easily avoided.
Magnesium supplerrents must be added simultaneously at half the dosage
of calcium supplerrents (Abraham, 1982; I.auersen & Stukane, 1983).
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'Ihe :rragnesium-pyridoxine deficiency theory of PMS has net with the
greatest success of all PMS treatrrents for the vast najority of patients
who suffer with mild to rroderate syrrptorns.

In every syrrptom complex of

PMS, symptoms have been relieved by this treat:rrent plan to sooe extent,
and proven superior to placebo (Chakrrakjian, 1983).

other dietetic

reccircm:::mdations cormon in the literature are (1) limiting the intake of
dairy products to two servings per day, (2) limiting alcohol intake to
one ounce per day, (3) eliminating all methylxanthine-containing
substances, (4) following a low-sodium/low-refined sugar/high-complex
carbohydrate diet, and (5) eating .srrall, frequent meals rather than
three large meals per day (Abraham, 1983b; Budoff, 1983; Lauersen &
Sttlkane, 1983).
Deficiency of prostaglandin E (PGE), zinc, and vitamins Band C
probably plays a :rrajor role in the experience of prenE11str:ual food
cravings, headaches, binging, palpitations,. and fatigue (Wilson, 1984).
Nonra.lly, PGE suppresses the body's insulin respJnse to sugar and
minimizes nervous responses to the lowered blcxXl sugar.

But if PGE is

deficient, a woman will experience tension and anxiety.

During the

late luteal phase, a woman's body is rrore responsive to insulin.
Eating an excess of refined carbohydrates can trigger an insulin
release.

Insulin prevents the kidneys from excreting salt, thereby

aggravating the prerrenstrual fluid retention problem.

Highly refined

sugar forces tryptophan into the brain where it is converted into
serotonin.

Too

Itn.lch serotonin causes palpitation and drowsiness.
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Refined sugar triggers insulin release, but in excess of what is
actually needed by the bcxly (Abraham, 1983b; I.auersen & Stukane, 1983).
If a woman waits too long between eating meals, her blcx:rl sugar
rnay drop, possibly involving a deficiency of PGE.

She may binge as a

result of her premenstrual tension and as a solution to her resultant
fatigue; hence, the vicious cycle.
ch~olate

during the luteal phase.

Some patients specifically crave

Not only does

ch~olate

contain

methylxanthine, but it is rich in magnesium, leading some theorists to
believe that this is the body's way of comensating for the deficiency
in magnesium (Iabrum, 1983).

It is also rich in phenylethylarnine, a

substance similar to dopamine (Abraham, 1982).

When PMS patients are

educated as to this pattern and its biological causes, they are rrore
likely to be able to limit their intake of refined sugar and refined
carbohydrates and to make the other necessary changes in their diet.
Warren who experience breast symptorrology have been helped by
600 units per day of vitamin E and the elimination of all rrethylxanthines
(Abraham, 1983b).
with

fibr~stic

'Ihese two treat:rrents are carnrronly used for patients
breast disease, another condition which worsens in the

luteal phase (London et al., 1983).
Another contributor to vitainin

B6 and magnesium deficiencies is

the oral contraceptive pill (Wilhelm-Hass, 1984).

A synthetic

progesterone, or progestin, is used instead of the natural horrrone
when manufacturing the Pill.

Progestins are either useless in the

treatrrent of PMS (Chakm3.kjian, 1983), or they make the the patient's

24

symptoms \6K:>rse (Clare, 1979; Dennerstein et al., 1984).

'Iherefore,

the Pill is seldom used as a treabnent for PMS.
Serre warren who fail to respond to progesterone or pyridoxine

therapy have experienced relief of their PMS symptoms when placed on a
dietary supplerrent containing a rare, essential fatty acid,
gamna.-linoleic acid (GIA), found in evening primrose oil (Chakrnakjian,
1983; I.abrurn, 1983).

So many factors interfere with the conversion of

this essential fatty acid, such as stress and a high-sugar/highcarbohydrate diet, that very high doses may be required (Horrobin &
Phil, 1983).

It is especially effective for depression, irritability,

breast symptoms, and fluid retention, and has been validated by three
double-blind, placebo controlled studies (Horrobin & Phil, 1983).
Prolactin
PMS may be caused in part by the body's inability to regulate the
horrrone, prolactin (Chakmakjian, 1983).
throughout the menstrual cycle.

This honrone is produced

But it is during the luteal phase,

rather than the follicular phase, where nn.ich nore variability exists in
plasrra. prolactin levels (Steiner & carroll, 1977).

Brarocriptine, a

potent prolactin antagonist manufactured by Sandoz, Inc., suppresses
the secretion of prolactin from the anterior pituitary (Steiner &
Carroll, 1977).

In patients where 2.5 rrg. of brorrocriptine was given

two tlires daily during the luteal phase, symptans such as nastydonia,

edertE., weight gain, and rrood disturbance were relieved (Budoff, 1983;

Chakmakjian, 1983).

Although there are possible adverse side effects,
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brorrocriptine has been shown to be superior

to

placebo and is therefore

a valuable option for wcnen (Shangold & Shangold, 1984).
Gynecologists should consider PMS treatnent for patients who have
fertility problems associated with hyperprolactinemia (Labrum, 1983).
A patient who has hyperprolactinemia has increased levels of prolactin
in her blood, which may lead to galactorrhea.
associated with llnpotence.

In

TIEI1,

it has been

It is often, but not always, associated

with micrcxlenoma of the anterior pituitary.

In one exciting study,

the nutritional treatment approach to PMS was given to infertile
warren with PMS symptannlogy.

'Ihese patients experienced relief of

their symptoms and the conception rate for the group beca:rre 86%
(Hargrove

&

Abraham, 1983).
Prostaglandins

Prolactin is the precursor to prostaglandins, chemicals which are
prcx:luced throughout the .brain, breasts, gastrointestinal tract, kidneys,
and reproductive tract.

These substances are prcx:luced wh8Il unsaturated

fats in the diet are altered by enzymatic reactions.

.Many PMS clients

experience fluid retention, breast tenderness, joint pain, and. migraine.

Wa:nen with dysmenorrhea have proven to have elevated prostaglandins.
For the past ten years, anti-prostaglandins such as rcotrin, ponstel,
naprosyn, and anaprox, have been used to inhibit the synthesis of
prostaglandins in order to control dysmenorrhea.

Researchers have

found that in m::>st cases, the symptans of prostaglandin excess resemble
those of PMS and several studies indicate that the PMS symptans
nentioned above decrease with these rredications (Budoff, 1983).

PSYCHIATRIC AND PSYOIOL03IC ASPECTS OF PMS
In the past, wonen often chose not to report their prerrenstrual

symptans, and those who did seek assista,nce from their doctors were
often thought to be errotionally unstable or irrational (Laughlin &
Johnson, 1984).

Farly psychological theorizing regarding PMS focused

on psychcxlynamic constructs.

For example, sarre psychodynamic theorists

have :postulated that psycho-social factors precipitate PMS (Budoff,
1983).

such factors include anxiety regarding rrotherhood (Bernsted

et al., 1984; Wilson, 1984), negative attitudes toward female genitalia
and menses (Bernsted et al., 1984; Budoff, 1983), unacceptable feelings
due to the lack of control over menstruation (Bernsted et al., 1984;
Wilson, 1984), guilt feelings about sex (Wilson, 1984), neuroticism
(Dennerstein et al., 1984; Wilson, 1984), poor :rrarital and sexual
adjustlrent (Budoff, 1983; Wilson, 1984), and self-esteem problems
related to the acceptance of the "feminine role" (Dennerstein et al.,
1984).

One researcher believes that these theorists have exaggerated

the detenninative effect that socialization has on experience (Koeske,
1983) •
PMS symptam::>logy has been interpreted as evidence for a distinct
psychologic cycle, in addition to a physiologic cycle.

Psychodynamic

explanations for such a cycle include (1) an i.rrq;>overished ego due

to

either (a) a "yearning for love" and a "state of helpless defenselessness" or (b) an angry defense to the "anticipation of attack and
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feelings of vulnerability", or (2) conflicting psychodynarnic tendencies
involving problems from early infancy, especially as they relate to
identification with the nother (Bernsted et al., 1984).
An attribution theory has also been proposed connecting negative
rrood swings to the approach of menses.

For example, one researcher

studied two groups which were at the sane phase of their :rrenstrual
cycles.

'Ihe researcher found that subjects who were led to believe

that menstruation would begin in one or two days reported a higher ,
degree of distressing sympta.ns than those women who thought they were
internenstrual (Demnerstein et al., 1984).
Sorre personality theorists have studied PMS in relation to
personality type.

'Ibey concluded that the PMS client is often unstable,

suspicious, prone to guilt, apprehensive, tense, and unable to
effectively cope (Dennerstein et al., 1984).

It is ll'rportant to

remember that whether such factors are the cause or the result of PMS
was not discemable (Dennerstein et al., 1984), and that fornal
psychotherapy has not proven to be useful in the treatrrent of PMS
(Laughlin

&

Johnson, 1984).

Current research supports

th~

theory that the physiological

syrnptans in women who suffer from PMS are, in all probability, the
primary symptoms, and that the errotional and behavioral symptoms are
secondary, as a consequence of the biochemical changes that c:x:cur
during the honn:::mal fluctuations of the rrenstrual cycle (Cllaknakjian,
1983).

'Ihe psychological canponents may occur with or without the

sanatic changes which take place during the premenstruum, or luteal
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phase (Abplanalp, 1983b).

As we have seen, the literature contains a

wide variety of reports of luteal phase changes in m:x:x1 states,
behaviors, and sexual feelings.

In their practices, clinicians have

found severe depression, uncontrollable irritability, and extrerre
hostility, symptoms which can be so severe that these :patients are nore
likely to attempt and succeed .at suicide, abuse their spouses and
children, have alcoholic bouts, and worsen or decanpensate if they are
already suffering from an affective disorder or schizophrenia (Budoff,
1983; Dennerstein et al., 1984; Greenfield & Wolf, 1983; Lahmeyer, 1984;
Steiner & Carroll, 1977).
It has been well dccmrented that both psychiatric . emergencies and
psychiatric hospitalizations occur rrore frequently during the
pre:rrenstruum (Clare, 1983; Dennerstein et al., 1984).

Although these

are the very wc:nen who are rrost in need, the current knowledge about
etiology and treat:rrent is inadequate to completely help them (Abplanalp,
1983b).

Oftentimes, the PMS client will first approach the psycho-

therapist for help, concerned that her symptcms are "all in her

hea~"

or because her doctor has failed to properly evaluate her PMS disorder
(Greenfield & Wolf, 1983; Norris, 1983).

In one study, 50% had first

received traditional psychotherapy prior to learning they were actually
suffering fran PMS (Norris, 1983).
Affective Disorders
Prerrenstrual symptoms usually exist without the presence of an
affective disorder.

But if a woman clearly evidences psycho:pa.thology,

she is at risk for rrore frequent, rrore severe, and nore diverse
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episodes of PMS symptcnolCXJY (Lah:rreyer, 1984; Steiner & Carroll, 1977).
She also probably has a sarrewhat greater risk for prerrenstrual affective
symptoms (Hamilton, 1984).

It has been reported that patients with a

history of affective disorders were much m:::>re likely to experience not
only premenstrual depression, but also m:::>re scrratic symptans than
nonpatients (Lah:rreyer, 1984).
Depression
Depressed patients undergo psychiatric admissions nore often during
the paramenstrual period of late luteal phase and rrenses.

One study

found that 69% of the depressed patients were admitted during this
phase (Dennerstein et al. , 1984) .

The actual depressive episode may be .

brief, lasting only a few days and then relieved by the onset of
rrenstruation, but the episode may be so deep as to reach a suicidal
level or temporary psychosis (Steiner & Carroll, 1977).
If a client already suffers from chronic depression, her
depression might worsen premenstrually (RubinON & Roy-Byme, 1984).
Syrrptorns during the rrenstrual cycle can include anhedonia, loss of

libido, change in appetite, sleep problems, and suicidal ideation.
Anti-depressant medication is often helpful (Labrum, 1983).
An

increase in libido is often a symptom of pre:rrenstrual syndrarre.

If a woman experiences depression, whether or not PMS is involved, she
may also experience a decrease in libido.

Special notice should be .

given to this syrnptan of change in libido, since an increased libido

in the luteal phase might help to differentiate PMS from a depressive
disorder (Norris, 1983).
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Postpartum Depression
Because of the fema.le preponderance for depression, the correlation
between PMS and depression is of s:pecial significance (Hamilton et al.,
1984).

PMS is usually triggered by a major horrronal change, such as

pregnancy, and it has been estirra.ted that as many as 90% of all warren
who experience postpartum depression eventually becare sufferers of
prerrenstrual syndrane (Iauersen & Stukane, 1983).
Manic-Depressive Illness
Before diagnosing a client as having manic-depressive illness,
it is critical to check for a possible cyclic pattern in syrnptomology
that may relate to her menstrual cycle.

The change from depression to

mania may occur between the last day of the luteal phase and the
first_ day of rrenstruation, giving the clinician the impression that the
client has ''returned to nonral'' when, in fact, her PMS symptoms have
actually been relieved by the onset of rrenses.

'Iherefore, it is

necessary to ascertain a detailed history to see if previous highs and _
lows have been related to the menstrual cycle (Labrum, 1983).
On one occassion, lithium carbonate was successfully used as the

treatment for PMS (DeLeon-Jones, Val,

&

Herts, 1982).

However, it is

not usually recarrm2I1ded for the treatm:mt of PMS since rrost studies
show no significant statistical difference between lithium and placebo,

and because of the adverse side effects (Chakrrakjian, 1983).
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Schizophrenic Disorders
Several studies have shown that patients with schizophrenic
disorders experience a psychiatric admission rate increase during the
luteal phase, again deironstrating their increased risk for the
exacerbation of PMS symptoms if psychopatholbgy exists (Dennerstein
et al., 1984; La.hrreyer, 1984).

Warren with schizophrenia often

decampensate prem:mstrually (Labrum, 1983).

A woman who has PMS without

a schizophrenic disorder ma.y experience feelings of paranoia, but will
not typically experience visual or auditor.y hallucinations or the
feeling that someone or something is controlling her (Labrum, 1983).
In order to make this important differential diagnosis, the clinician
might employ either all or part of the Minnesota Multiphasic
Personality Inventor.y (MMPI) in conjunction with his/her psychiatric
evaluation (Laughlin & Johnson, 1984; Sampson & Prescott, 1981).
The Arrerican Psychiatric Association's Diagr}ostic and Statistical
Manual of Mental Disorders, ccm:ronly known as DSM-III,· has no current
classification of psychiatric disorders for psychosis, affective
disorder, or personality disorder occurring in relationship to rrenses
(Dennerstein et al., 1984).

If the clinician is unaware of the cyclic

nature of the client's symptc:.a10logy, he/she ma.y mistakenly diagnose
Generalized Anxiety Disorder (300.02), Cyclothymic Disorder (301.13),
Dysthymic Disorder (300.40), or Brief Reactive Psychosis (298.80)
(Backstrom et al., 1982; Greenfield & Wolf, · 1983).

It is of critical

importance that we study PMS through research which focuses on the role
of neurotransmitters and neurom:rlulators believed to regulate affective
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disorders.

Affective disorders and PMS both have unknown biochemical

etiologies, but the technology for understanding the biochemical
pararreters of m:xx1 states is fairly advanced in comparison to the
current state of knowledge regarding the etiology of PMS (Janowsky,
1985).

COUNSELING STRATffiIES
'Ihe importance of supportive counseling for the PMS client should
not be underestinated.

'Ihe psychological, not the physical, syrrptans

usually create the greater difficulty for the PMS sufferer and her
family (Wilhelm-Hass, 1984).

'!he ID2!1tal health professional needs to

set up two screening appointments in order to evaluate a worran who
nay have prerrenstrual

syndro~.

'Ihe initial visit should occur during the follicular phase and
the second should be during the luteal phase (Wilhelm-Hass, 1984).
Presumably, the client will be asymptorratic during her initial visit.
At this visit, the client should be allowed to ventilate her feelings
and frustrations regarding her symptoms and their ramifications.

The

trusting relationship desired between the psychotherapist and client
rrust begin with the therapist's acknowledgment of PMS as a real
disorder that is biochemical in origin and not psychosonatic (Clare,
1983; Wilson, 1984).

Education about the honronal changes in the

nenstrual cycle and the characteristics of PMS are extrerrely important,
and ample time should be allowed to answer questions and to provide the
client with the PMS Reading List (see Appendix II).

At the end of the

session, the PMS Assessrrent Questionnaire (PAQ) should be filled out by
the clinician in the ongoing interview (see Appendix II).

This affords

the client an .opportunity to describe in detail her unique symtarology.
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During this initial visit, the client should be instructed as to
how and why she needs to canplete the Basal Body Temperature Report (BBT)
and the Menstrual Syrrptoms Calendar (MSC) (see Appendix II).

'Ihese

rceasures help the client to understand the cyclic nature of PMS and
provide an opportunity for her to be involved in her own treatm:mt
(Wilson, 1984).

She should be instructed to bring them with her on

her next scheduled visit.
At the second interview, the psychotherapist and client should
review the MSC and BBT together.

Since a minimum of two rrenstrual

cycles will not have elapsed between the first and second appointments,
the clinician should use this visit, and perhaps the next, to listen to
and reflect for the client, rather than diagnose.

She should be

instructed to continue charting her temperature and syrrptcms for at
least two, and preferably three, :rrenstrual cycles.
'When two cycles have pa.ssed, the psychotherapist and the client
need to review the charts together to determine whether o:r:- not her
symptoms actually coincide with her luteal phase (Wilhelm-Hass, 1984).
If it does not appear that she has PMS, the psychotherapist needs to
confront his/her client.

Hopef~lly,

she will understand and accept

the alternative diagnosis and reasons why she does not have PMS.

If so,

she nay be ready and willing to work on the psychological issues that
are creating problems for her.
If she does appear to have PMS, she needs an .innediate referral
a gynecologist for a complete examination.

to

It is inportant to

prospectively, rather than retrospectively, confirm the existence of a
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a client's PMS prior to her beginning a treat:m:mt program (Rubinow,
Roy-Byrne, Hoban, Gold,

&

Post, 1984).

As a supportive measure, the ·

therapist should send a written report with her BBT and MSC to the
doctor prior to her appointrrent.

From here on, it is advantageous

for all concerned if the physician and rrental health professional
work together.
While the client is being seen by her gynecologist, a psychotherapeutic treatment plan should be decided upon.

If her symptcrns

are mild to rroderate, she can be educated as to the dietetic and
lifestyle changes which hopefully her gynecologist has already
recorrrrended for the relief of her symptoms.

Exercise reduces stress

which is known to exacerbate PMS symptoms (1.a.uersen & Stukane, 1983;
Shangold, 1983).

Outdoor exercise is preferable to indoor exercise

for the relief of PMS (Abraham, 1982).
If, however, the client presents an errergency situation in which
she ( 1) is a danger to herself or others, ( 2) is having or is about to
have an alcoholic bout, or (3) is experiencing a psychotic episcx:le,
then clearly the situation demands rrore imrrediate treat:rrent than what
has been outlined above.

'lhe rrental health professional should contact

a gynecologist knowledgeable about PMS and/or a psychiatrist before
dismissing the client if appropriate.
The best treatment for the majority of PMS sufferers appears to be
supportive counseling with the nutritional/exercise approach outlined
earlier (Norris, 1983; Wilhelm-Hass, 1984).

PMS clinics have begun to

spring up around the country, with the first clinic opening in Boston
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in 1979.

'Ihe number of clinics currently functioning is inadequate to

rreet the demand (Greenfield & Wolf, 1983; Rubinow, Roy-Byrne, Hoban,
Gold, & Post, 1984).

But the alternative is for rrental health

professionals to educate themselves and work directly with the rredical
profession.
Because PMS varies so rruch from woman to wanan, an individualized
treat:rrent approach is necessary (Abplanalp, 1983b).

A waran rna.y need

relaxation techniques, crisis-counseling, individual short-tenn
psychotherapy, marital or couple counseling, family therapy, a PMS
support group, or a cc:robination of these therapeutic options.
Individual Psychotherapy
A woman suffering from premenstrual syndrare may feel guilt and

depression for past behaviors during her prem:mstruum.

She may be

suffering from shame and self-esteem problems after :rronths or even
years of self-deprecation and degradation as a result of not having
received treat:rrent for her PMS symptoms.

She may feel inadequate and/or

· helpless in her personal and professional roles, and may be concerned
that her behavior has hurt her children (Greenfield

&

Wolf, ·1983).

Control is an issue if the woman feels that her PMS governs her
whole life.

She needs to be ma.de aware that actually her symptans only

occur two weeks or less each rronth, and that she will feel nore
in control again with the appropriate treatm:mt (Hamilton et al., 1984) •

Typically, wanen have been viewed as manipulative if, in fact, they
are able to contain their anger three weeks out of four every nonth,
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then seeming to let go of this control (Hamilton et al., 1984; Lahrreyer,
1984).

Warren have been socialized to withhold expressions of anger,

and when they find themselves unable to continue doing so, they then
have to deal with feelings of guilt, denial, egodystonia, and perhaps
even rrore anger.
If she has been abusing alcohol or drugs to alleviate her syrrptorns,
she may suffer decreased coordination, poor judgrrent, disorganization,
and poor attention s:pan (Greenfield & Wolf, 1983).

It has been

estirna.ted that there are two million alcoholic waren in the reproductive
age group in America.

Sixty-seven per cent of alcoholic warren related

their drinking to the menstrual cycle, drinking to relieve their
pre:rrenstrual tension and anxiety, in one study (Labrum, 1983) .

One of

the primary therapeutic goals for these women has to be sobriety, and
Alcoholics Anonyrrous or a PMS supi;x:>rt group may help to bring about
this change.
Other goals in therapy should include coping strategi..es, irrproved
job satisfaction, assertiveness training, ways to reduce stress, and
strategies for avoiding i;x:>tential problems at horre and on the job during
the prem:mstruurn.

'Ihe 11'61tal health professional should provide support

in all aspects of the client's treatrcent plan.

Marital and Family 'Iherapy
Supi;x:>rt from family m=mbers is crucial in helping the client to
naintain her place in the family structure.

Her self-worth nay have

been diminished if her behavior caused her sharre or rerrorse.

During

the prenenstruurn, she may be explosive, critical, and unreasonable.
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It ma.y no longer be easy for her to trust others or share confidences
(Long, 1985) •
Education for the family members is important for her and them,
so that they can understand what she is going through (Ahlgri.rcm, 1985).
The family can be active in treabrent by ccx.:>perating to devise a
coping strategy which can be put into effect premenstrually.

This

safety net strategy should be tailored to the needs and strengths of the
client and her family.

'Ihe family should be able to depend on the

ingenuity and skills of the psychotherapist to devise such a plan.
Control is an issue here also because her husband may feel that her
symptans control the marital relationship and/or the family dynamics,
or because he ma.y want his wife "controlled" by medication (Clare, 1983;
Hamilton et al., 1984).

Infertility problems exacerbated by PMS may be

an issue in ma.rital or couple therapy.

'Ihe psychotherapist needs to

assess the different familial relationships, the relationships with
friends and neighbors, and professional relationships.
Support Groups
'Ihe group therapy fonnn provides a unique, therapeutic experience
for the PMS client.

These warren can validate their feelings and the

feelings of others by sharing their experiences.

Information about the

etiologies and treatments of PMS can also be shared during these group
meetings.

Feelings such as grief, guilt, rerrorse, anger, and inadequacy

can all be dealt with in the confines of an understanding group setting.
Worcen

can support each other in their nutritional and exercise treatnent

plans, and deal collectively with the issue of control (Koeske, 1983).

IMPLICATIONS FOR FURTHER RESEARCH
Further studies dealing with the causes and treatrrents of PMS
need to address previous methodolog-ical problems.

Sane

of these

rrethodolog-ic flaws are reviewed here.
Definition
Problems include the lack of a consensus am::mg researchers and
clinicians concerning the combination and variety of syrnptans,
criteria for subject selection, and relationship of psychiatric
disorders.

'Ihe number, variety, severity, and duration of symptoms

vary widely a:rrong studies, subjects, and cycles (Abplanalp, 1983a).
'Ihey can also differ within the same worran (Abplanalp, 1983a; Backstrom
et al., 1983).

'lhe t.ilre of onset and course of syrnptorrology is

variable in the literature, even to the degree that different
researchers define "prerrenstrual" and "syndrorre" differently
(Abplanalp, 1983a).

It is interesting to note that one estirrate

indicates that only 20% of wan:::m rrenstruate "regularly" (Lahrreyer,
1984).
Because of the absence of an agreed-upon definition for PMS,
experimental designs are often the result of the researchers'
philosophies.

'Ihis constancy criteria for subject selection and

rrethcrl needs to be employed across studies (Abplanalp, 1983a).
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Retrospective Versus Pros;pective Symptan Rating
Several studies discuss the problems encountered when research
subjects report their premenstrual syrrptorns retrospectively rather than
prospectively.

'!he retrospective method has been found to canpramise

the PMS literature because such ratings are inaccurate by tending to
overestinate the symptoms experienced (Golub, 1984; Harrison et al.,
1984; Janowsky, 1985; Iahmeyer, 1984; Rubinow, Roy-Byrne, Hoban, Gold, &
Post, 1984; Sampson & Prescott, 1981; Sanders et al., 1983; Wilhelm-Hass,
1984).

'!he recent developm=nt of a daily, longitudinal rating scale has

addressed this problem with sorre success (Rubinow, Roy-Byrne, Hoban,
Gold,

&

Post, 1984).

'Ihe graphing of daily, prospective ratings with

visual analogue scale scores has proven useful for several reasons, such
as simplicity and the allowance of the evaluation of severity as it
relates to irenses, but nost importantly because it meets the proposed
National Institute of Mental Health (NIMH) criteria for the diagnosis
of PMS (Hamilton et al., 1984).

'Ihe 1983 NIMH conference specifically

reccmrended that researchers derconstrate their subjects as having
(1) a narked change of about 30% in the intensity of symptans rreasured
intenrenstrually, from cycle days 5 - 10, as compared to that
premenstrually, during the six-day interval prior to m:mses, and (2)
the recording of these changes for at least two consecutive m:mstrual
cycles (Hamilton et al., 1984).
Placebo Effect
Oftentimes, placebo-controlled trials have been lacking, or if
utilized, have either failed to show a significant statistical
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difference or evidenced placebo to be just as effective or even nore
effective than the treatrcent on trial (Abplanalp, 1983a; Abplanalp,
1983b; Harrison et al., 1984; Janowsky, 1985).

'!he wide .range of

placebo response, estircated to be between 30% and. 80% de:pending upon
(1) the treatment being tested and (2) variable results anong studies,
has been blamed for the pessimistic attitude about the ability to
derronstrate the efficacy of drug therapy, thereby creating a decline
of interest in PMS research (Harrison et al., 1984).
Treatrrent
It has been recomrended that future studies be well controlled
and double-blind because the rrajority of PMS treabrent studies have
involved open, uncontrolled trials which exclude the accurate
evaluation of the therapy being considered (Abplanalp, 1983a;
Chakrrakjian, 1983).

'Ihe high placebo response is another reason for

better controlled studies (Olakmakjian, 1983).

The absence of

replication in studies is also frequently found (Sanrer, 1983).
SUbject Selection
'Ihere needs to be an adequate number of participants and the
duration of the study needs to be long enough to validate the efficacy
of the treai:rrent on trial (Cllakmakjian, 1983; Sampson & Prescott, 1981).
The populations sorretirres employed for empirical studies have been
too young (Slade, 1984).

'Ihis error not only invalidates the study,

but also has ircplications in the determination of an operational
definition of PMS (Golub, 1984). ·
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Phase Designation
It has been suggested that the Scx:iety for Menstrual Cycle
Research, endorsed by Divison 35 (Psychology of

Warren)

of the American

PsycholCXJical Asscx::iation (APA) (Koeske, 1983), establish guidelines
for the designation of menstrual phases (Somer, 1983).

Such a

detennination would decrease the large selection of phase specification
currently found in the research, and provide for :rrore harrogenous results
in accordance with generally accepted guidelines (Chaknakjian, 1983;
Sanders et al., 1983; Sorrmer, 1983).
Nonsexist Research
Gender-based biases have effected the way some irenstrual cycle
research has been designed, evaluated, labeled, and utilized.

One

researcher strongly emphasizes the need for a feminist perspective
when studying the menstrual cycle (Koeske, 1983).

She notes that ·

Guidelines for Nonsexist Research was endorsed by the APA in ·Decernber
of 1981, and that the docmrent was the result of

two

years of work done

by a national task force of psychologists (Koeske, 1983).
Cycle Research
One study suggests that future research include (1) the study of
rrood changes in the presence of abnonral hornonal cycles, such as an

anovular cycle, and during times of change in cyclicity, such as
adolescence and the post:parturn period following lactation, and (2) the
COlllJ?arison in the sane worran of horrronal cycles with and without cyclic
rrocx:l change (Backstrom et al. , 198 3) •

It has been proposed that
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biochemical tests with serial honronal rreasurerrents in the control
and experinental trials might contribute to the understanding of the
pathogenesis of PMS (Chakrrakjian, 1983).

Further research into the

cyclicity of m:x:xi in both rcen and warren might also lead to this goal
(Golub, 1984; Hamilton, 1984; Shangold & Shangold, 1984).
Finally, recent research indicates the i.rrportance of focusing on
positive nood which coincides with the estradiol peak during the
follicular stage, in contrast to the current practice of focusing on
the negative rrood during the premenstruum.

such a change of focus

might provide a better understanding of the entire scope of m::x:xl and
the menstrual cycle (Abplanalp, 1983b; Backstrom et al., 1983;
Dennerstein et al., 1984; Sanders et al., 1983).

APPENDIX I .

TYPICAL MENSTRUAL CYCLE OF A EUMENORRHEIC VOvlAN

LU TEAL
PHASE

FOLLICULAR
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+-'
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mid-follicular
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.
(Adapted from Sanders et al., 1983; Steiner

LH peak)

I

I

&

Carroll, 1977)

APPENDIX II
PMS PACKE'T FOR MENTAL HEALTH PROFESSIONALS
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PMS Reading List
Facts About Dysrrenorrhea and Prerrenstrual Syndrorre, a pamphlet from
the National Institute of Health. Write to: Office of Research
Reporting, NICHD/NIH, Building 31, Rocm 2A32, 9000 Hockville Pike,
Bethesda, MD 20205.
Once A Month. '!he Prenenstrual Syndrcrne: What It Is and How to Free
Yourself frcxn Its Effects, by Katharina Dalton, M. D., Hunter House,
Porrona, CA, 1979.
PMS ACCESS Newsletter, available by subscription from PMS Access,
P. 0. Box 9326, Madison, WI 53715. (Six publications :per year cost
$15.00)
PMS: Premenstrual Syndrorre and You, by Neils H. Lauersen, M. D. and
Eileen Stukane, Pinnacle Books, New York, NY, 1983.
Premenstrual Blues, by Guy E. Abraham, M. D., Optirrox Corporation,
Torrance, CA, 1985. Available from Health Options, P. o. Box 1917,
Aptos, CA 95003.
Premenstrual Syndrome: The CXids Are Al.rrost Even, Madison Pharmacy
Associates, Inc., Madison, WI, 1985. Available from Madison Pharmacy
Associates, Inc., 1603 M:mroe Street, Madison, WI 53711.
Premenstrual Syndrorre Self-Help Book, by SUsan M. Lark, M. D., Farnan
Publishing, Los Angeles, c.A, 1984.
Premenstrual Syndrome and You, by Elizabeth White, Budlong Press Co.,
Chicago, Il, 1985. Available from the Budlong Press Company, P. O.
Box 31032, Chicago, IL 60631-1032.
Self-Help for Premenstrual Syrtdrorre, by Michelle Harrison, M. D. ,
Random House, Inc., New York, NY, 1985.
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PMS Resources in Central Florida
The Center for Wane.n's Medicine at Florida Hospital
Florida Medical Plaza/Outpatient Center
Billie Jean Pace, M. D. (Obstetrics/Gynecology)
2501 North Orange Avenue, SUite 340
Orlando, FL 32804
(305) 897-1617
Anne Diebel, .Psy. D.
377 Maitland Avenue, SUite 207
Alta:rronte Springs, FL 32701
(305) 831-5211

Erm¥ K. Freerran, Ph. D. (Clinical Psychology)
1910 E.ast Hillcrest Street
Orlando, FL 32803
(305) 896-0136
Jeffrey R. Koren, M. D. (Obstetrics/Gynecology)
685 Palm Springs Drive, Suite E
Altarronte Springs, FL 32701
(305) 831-0645
Don Diebel, M. D. (Obstetrics/Gynecology)
SUsan Epley, M. D. (Obstetrics/Gynecology)
1551 Clay Street
Winter Park, FL 32789
(305) 644-5371
Robert Oullette, M. D. (Obstetrics/Gynecology)
800 West Plyrrouth Avenue
DeLand, FL 32720
(904) 736-1404
Samuel s. M:=Clure, M. D. (Psychiatry)
Palm Bay Counseling Center
1520 Bottlebrush Drive, Northeast, Unit #2
Palm Bay, FL 32905
(305) 724-1614
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Janes Harrell, M. D. (Obstetrics/Gynecology)
Larry Holder, M. D. (Obstetrics/Gynecology)
707 Osceola
Stuart, FL 33494
(305) 283-1177
Neil Boland, M. D. (Obstetrics/Gynecology)
314 Hospital Avenue
Stuart, FL 33494
(305) 287-5590
Stephen Coleman, D. O. (Obstetrics/Gynecology)
S. H. E. Center·
600 Bypass Drive, SUite 111
Clearwater, FL 33546
(813) 799-3509
Steven Walden, M. D. (Obstetrics/Gynecology)
2817 West Virginia Avenue
Tampa, FL 33607
(813) 870-0286
Albert Cohen, M. D. (Obstetrics/Gynecology)
2708 Azeele
Tampa, FL 33609
(813) 872-8376
Beth Benson, M. D. (Obstetrics/Gynecology)
St. Petersburg Wcnan's Clinic
700 6th Avenue South
St. Petersburg, FL 33701
(813) 896-0051

PMS ACCESS provides a toll free number which can be used to ascertain
knowledgeable physicians in your area: 1-800-222-4PMS, Monday - Friday,
9:00 AM - 5:30 PM, Central time.
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Instructions for Basal Body Temperature Record (BBT)
1)

Insert the date (month/day) at the top of the colUim.

2)

Each morning when you awake, but before you get out of bed, place a
basal therrrorreter under your tongue for two minutes. Lay quietly
and do not speak. Do not skip a rrorning, even during menstruation.
(If you forget one morning, do not guess. Simply leave that entry
blank). Do not eat, drink, or srroke prior to taking your
temperature.

3)

Record your temperature on the graph.

4)

The first day
Note each day
column m:trked
appear to the

5)

Any rredication taken should be noted on the corresponding day.

6)

lmy reasons for temperature variation (flu, insamia, head cold,
etc . ) should be noted on your graph.

7)

Using only one graph :per cycle, ccrnplete three consecutive cycles.

of menstruation is the beginning of your cycle.
of flow by blackening the square on the graph in the
"menstruation". Blackened squares should always
far left of your graph.

(=nlmpk)
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Instructions for Menstrual Symptoms Calendar (MSC)
1)

At the end of each day, fill in as many symptoms as are applicable
that you experienced that day. Please use the MSC Key to note your
symptoms.

2)

Next to each symptom, please note the intensity of that symptom
with an appropriate rating: 1 = mild
2 = rroderate
3 = severe

3)

It is very .i.rrq;:ortant that you do this each night, and not try to
recall your symptorns at a later date.

4)

On the days you rrenstruate, mark an@in the corner of that day.

If you exper.ience cramps, backaches, or any other symptom associated
with rrenses, please note.
5)

If you take any rredication to relieve your symptom(s), please be
sure to note the narre of the medication and the anount on the
appropriate day.

6)

If you are taking an oral contraceptive, m:rrk one corner of the day
you do so with a

7)

It is not necessary for you to wait until the first day of rrenses
to begin the MSC.

8)

Keep a MSC for three consecutive nonths.

®

NOI'E:

If you experience syrrptarns not m::mtioned in the Key, please
write them down and rate them (i.e., -worsening of asthna,
allergy symptans, epileptic seizures, heightened sexuality,
excitem:mt, fear or feeling of losing control, etc.).
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MENSTRUAL SYMPTOMS CALENDAR (KEY)

I

PMS-A

PMS-H

I
I

Al =

I

anxiety

Hl =

heavy/bloated feeling

H2 =

breast tenderness

H3 =

backache

H4 =

joint swelling

H5 =

breast congestion

H6

sensation of weight
gain

I

A2 =

irritability

A3 =

nervous tension

A4 =

crying spell

I
I
I
I
I

A5 =

mood swing

A6 =

acne, cold sores

I
I
I

=

I
1

- - - - - - - - - - PMS-C
Cl =

= mild

2 = moderate

PMS-D

3 = severe

craving
(food or alcohol)

- - - - - - - - - - -

I

~

I

Dl

=

depression

C2

=

increased appetite

'

D2 =

hostility

C3

=

binging

I

D3

lethargy

I

=

I

C4

=

fatigue

C5 =

headache

C6

palpitations

=

I
I
I
I

D4 =

confusion

D5 =

paranoid ideation

D6 =

suicidal ideation

D7 =

insomnia

D8 =

difficulty with
verbalization

I

C7 =

dizziness

cs

faintness

=

I
I
I
I

Adapted f ran Abraham, 1983b .
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PMS ASSESSMENT QUESTIONNAIRE*
Date:
Narre:

Address:
Phone : (day)
age

-------

(evening)

- - - - - date of birth

-----~

marital status
occupation

---------------

************************************************************************
~nstrual

History

1.

Vvnen was your first menstrual period?

2.

How many days usually pass fran the beginning of one period to the
beginning of the next?

3.

.How many days does menstruation usually last?

4.

(a) Do you experience cramps with your period? (please check one)
(1) every period ____ only sanetimes ___ never _____
(2) cramps are mild ____ moderate · ___ severe _____
(b) If you take any medication for cramps, please note the type and
the rurount here.
(c) Have you ever been diagnosed as having dysrenorrhea?

*Adapted fran the PMS Action, Inc. Assessment Tool (PAAT).
(See Cassara, Virginia) .
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Pregnancy History
5.

Have you ever been pregnant? Yes

No

---

(If your answer is "no" , please go on to #9)
6.

How many times have you been pregnant?

7.

What is the m.nnber of ti.Ires you have given birth?

8.

During your pregnancy (or pregnancies) , did you ever experience
any of the following: toxemia , postpartum depression, complications?
Please elaborate and be as specific as possible as to the first,
second, or third trimesters.

9.

Have you ever had an abortion?

-----

-------

(If so, please give dates).

Oral Contraceptive History
10.

Do you take the birth control pill now?

Yes

11.

Have you ever taken the Pill in the past?

Yes

No

---

No _ __

If yes, please give dates.
12.

If you are currently taking the Pill, how long have you been
taking it? Please note any tlires you have gone off the Pill
for short periods as per your doctor's recanrendation.

13.

Was the Pill prescribed for birth control or for PMS symptans?

14.

How did (does) it effect you?

15.

If you have stopped taking it , please explain why you decided
to stop doing so .

*****************************************·***************************
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16.

Have you ever had any fertility problans?

Please explain.

17.

Are you now or have you ever been on any time of horrrone
therapy (other than the Pill)? Please explain.

18.

Have you ever undergone gynecological surgery (such as tubal
ligation, ovarian cyst, hysterectany, fallopian tubes, etc.)?
Please include dates of surgery and a brief explaination.

If you had a hysterectany, were both of your ovaries rerroved?

19.

Do you now or have you ever had fibrocystic breast disease?

If so, what treatment was provided?

Was it helpful?

20.

Have you ever had anorexia nervosa?

21.

What has been your highest adult weight (excluding pregnancy}?

Lowest adult weight?

22.

Do you have any allergies?

If so, please explain.

23.

How often do you have problems, if ever, with vaginitis?
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24.

Please put a check mark next to any of the following symptoms
which is a problem for you during your menstrual cycle. If you
know exactly what tirre of your cycle the symptom roost bothers you,
please note the information.
anxiety
irritability
nervous tension
crying spells
rrood swings
acne, cold sores
heavy/bloated feeling
breast tenderness
backache
joint swelling
breast congestion
sensation of weight gain
craving of food or alcohol
increased appetite
binging
fatigue
headache
palpitations
dizziness
faintness
depression
hostility
lethargy
confusion
~~ feeling paranoid
=feeling suicidal .
insomnia
~~ difficulty with verbalization

25.

Have you ever done any actual charting of the symptans to see on
which days of· your cycle they occur?
If so , how long have you been charting than?
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26.

Do you think that your prerrenstrua.l symptoms effect your
personal (family) life? If oo, please explain.

27..

Do you think that your premenstrual symptoms effect your
professional life? If so, please explain.

28.

Have your symptan.s changed over the years?

29.

When do you think the symptans first began?

30.

Do you feel l:::>etter when you begin to menstruate?

If so, please explain.

Yes

No

If you answered ''yes'':
Do your symptans end gradually - - -·
dramatically
with onset of flow

---

31.

---

Is it clear. that there is a tlire during your menstrual cycle · when
you do not experience· JJMS symptan.s?

If so , approximately how many days do you experience relief?

32.

Is verbal abuse a problem?

Physical aggression? (Please explain).
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33.

How have the symptans effected your sexuality, if at all?

34.

lb you experience an increase in libido, a decrease, or no
change?

35.

Do any other IIEmbers of your family (rrnther, sisters, daughters)

experience PMS symptcnnlogy?

36.

lb you abuse alcohol or other drugs? Have you noticed an inability
to tolerate alcohol prior to your period?

37.

What self-help treatIJEnts have you tried and with what success?

38.

How successful has your search for professional help been? What
specialists have you sought help fran and with what results? What,
if any, medications were prescribed?

39.

Please use this space to explain your daily eating patterns,
including caffeine and vitamin intake.
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40.

Have you ever been treated for a psychiatric illness? If so,
please state dates of treatment and types of treatment .

41.

Have you ever undergone a psychological or psychiatric evaluation?
If so, please state the circmnstances under which this was given.

42.

Have you ever been hospitalized for a psychiatric illness?
please give dates and diagnoses.

43.

Have you ever taken medication that was prescribed by a psychiatrist? If so ., please state type, amount, and dates of use.

44.

Please use this space to explain any other ongoing or previous
illnesses or injuries which you believe may be helpful in our
understanding of your canplete medical history.

If so,
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